Contract Development Services

Serialization deadlines will shortly be upon us – but, rather than entering into a blind panic, consider the long term.

Eva has some bad news for Gene in the latest edition of "Trials of a Medicine Maker."

The Medicine Maker's James Strachan speaks with Paul Evans from Johnson Matthey.

Sitting Down With… Tony van Bijleveld, BU Head of Softgels, Pharma Services Group, Thermo Fisher Scientific, the Netherlands.

Outsourcing partnerships aim to reduce costs and improve efficiencies, but don't overlook the human elements!

Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.

What does your product demand guesstimate look like, and how can you be sure things won’t suddenly change?

The US and and EU deadlines are approaching, but is the industry ready for serialization?

Scaling up a bioprocess doesn’t need to be a headache - especially when there are firms out there that can lend a helping hand

When making advanced medicines, the cost of manufacture must be lower than reimbursement